▶️ The Dawn of De Novo Biological Design
The convergence of Artificial Intelligence and Biotechnology has moved beyond predictive analytics into a new, transformative era: **Generative Biology**. No longer content with merely analyzing or optimizing existing biological systems, AI is now actively designing, synthesizing, and validating entirely novel biological structures, functions, and systems from first principles. This shift represents a fundamental re-architecture of how we approach drug discovery, materials science, and even agriculture, promising breakthroughs that were previously unimaginable.
